Pitcairn Co. acquired a new position in shares of Fresenius Medical Care Corporation (NYSE:FMS) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 8,516 shares of the company’s stock, valued at approximately $417,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of FMS. Harding Loevner LP increased its holdings in Fresenius Medical Care Corporation by 6.2% during the second quarter. Harding Loevner LP now owns 3,748,173 shares of the company’s stock worth $181,149,000 after buying an additional 219,213 shares during the last quarter. Renaissance Technologies LLC purchased a new stake in Fresenius Medical Care Corporation during the first quarter worth about $7,141,000. Cambiar Investors LLC increased its holdings in Fresenius Medical Care Corporation by 3.2% during the second quarter. Cambiar Investors LLC now owns 2,596,480 shares of the company’s stock worth $125,488,000 after buying an additional 80,064 shares during the last quarter. Crossmark Global Holdings Inc. purchased a new stake in Fresenius Medical Care Corporation during the third quarter worth about $3,259,000. Finally, Harbour Capital Advisors LLC increased its holdings in Fresenius Medical Care Corporation by 4,733.0% during the second quarter. Harbour Capital Advisors LLC now owns 67,662 shares of the company’s stock worth $1,400,000 after buying an additional 66,262 shares during the last quarter. Institutional investors and hedge funds own 2.62% of the company’s stock.
Fresenius Medical Care Corporation (NYSE:FMS) traded down $0.39 on Friday, hitting $48.42. 97,000 shares of the stock traded hands, compared to its average volume of 389,520. The stock has a market capitalization of $29,813.26, a P/E ratio of 21.71, a price-to-earnings-growth ratio of 2.18 and a beta of 0.45. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.22 and a quick ratio of 0.98. Fresenius Medical Care Corporation has a 52-week low of $38.05 and a 52-week high of $50.22.
COPYRIGHT VIOLATION WARNING: “Pitcairn Co. Acquires Shares of 8,516 Fresenius Medical Care Corporation (FMS)” was first posted by Markets Daily and is the sole property of of Markets Daily. If you are viewing this article on another site, it was copied illegally and reposted in violation of United States & international trademark and copyright law. The correct version of this article can be read at https://www.themarketsdaily.com/2017/11/12/pitcairn-co-acquires-shares-of-8516-fresenius-medical-care-corporation-fms.html.
Several research firms have recently weighed in on FMS. Zacks Investment Research downgraded shares of Fresenius Medical Care Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, October 3rd. BidaskClub downgraded shares of Fresenius Medical Care Corporation from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 24th. Royal Bank Of Canada reiterated a “neutral” rating and issued a target price on shares of Fresenius Medical Care Corporation in a research note on Tuesday, August 8th. Finally, DZ Bank AG reiterated a “buy” rating on shares of Fresenius Medical Care Corporation in a research note on Monday, August 7th. Two analysts have rated the stock with a sell rating, three have given a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $48.50.
About Fresenius Medical Care Corporation
Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.
Receive News & Ratings for Fresenius Medical Care Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care Corporation and related companies with MarketBeat.com's FREE daily email newsletter.